Track topics on Twitter Track topics that are important to you
Developing drugs for rare diseases is a tough nut for biotech companies to crack. Labiotech’s Helen Albert interviewed the CEO of the Danish company Orphazyme, Anders Hinsby, at the recent BIO-Europe conference in Copenhagen, who told her about the appeals ...
The post Navigating the Rare Disease Space: Insights from a Danish CEO appeared first on Labiotech.eu.
Original Article: Navigating the Rare Disease Space: Insights from a Danish CEONEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...